Mergers & Acquisitions News

IMab Biopharma Signs Agreement for Clinical Research of TJD5 in Combination Therapy: SHANGHAI April 11 2019 PRNewswire IMab Biopharma "IMab" a clinical stage biopharmaceutical company exclusively focused on the development of potential firstinclass and bestinclass biologics in immunooncology and autoimmun...

Philips and Vietnamese Hong Duc General Hospital sign multiyear strategic partnership agreement: 11 April 2019 Philips to provide turnkey hospital solution to newlybuilt Hong Duc General Hospital II including the latest medical imaging and healthcare IT solutions as well as design consulting and financing services Starting in early 2020 Hong Duc Gener...

Acetium lozenge for smoking intervention will be available in Thailand during the year 2019: Press release 11th April 2019 at 09.30 local time EEST Biohit Oyj and Precision Health Co. Ltd have signed an agreement for the distribution of the Acetium lozenge in Thailand. The effectiveness of Acetium lozenge in smoking intervention has been &823...

EVOTEC AND INDIVUMED ANNOUNCE STRATEGIC DRUG DISCOVERY COLLABORATION ON PRECISION MEDICINE FOR COLORECTAL CANCER: DGAPNews Evotec SE Key words Miscellaneous11.04.2019 0730 The issuer is solely responsible for the content of this announcement. THE COLLABORATION LEVERAGES INDIVUMED'S TRUE MULTIOMICS CANCER DATABASE "INDIVUTYPE" AND EVOTEC'S DRUG DISCOVERY PL...

EVOTEC AND INDIVUMED ANNOUNCE STRATEGIC DRUG DISCOVERY COLLABORATION ON PRECISION MEDICINE FOR COLORECTAL CANCER: DGAPNews Evotec SE Key words Miscellaneous11.04.2019 0730 The issuer is solely responsible for the content of this announcement. THE COLLABORATION LEVERAGES INDIVUMED'S TRUE MULTIOMICS CANCER DATABASE "INDIVUTYPE" AND EVOTEC'S DRUG DISCOVERY PL...

Sandoz drives differentiated portfolio with deal to commercialize new treatment for OpioidInduced Constipation in key European countries

Heidelberg Pharma AG Interim Management Statement on the First Three Months of 2019: DGAPNews Heidelberg Pharma AG Key words Quarter Results11.04.2019 0713 The issuer is solely responsible for the content of this announcement.Heidelberg Pharma AG Interim Management Statement on the First Three Months of 2019 Partner Link Health receives ...

ICYMI: CVSAetna Merger Judge Allows AHF to Propose Witnesses: Judge Richard J. Leon of the U.S. District Court for the District of Columbia ruled Monday that AIDS Healthcare Foundation AHF may propose up to three witnesses to testify at an upcoming evidentiary hearing in opposition to the near...

ICYMI: BrightInsight a Flex Company Receives 2018 Google Cloud Partner of the Year Award for Healthcare and Life Sciences: Built on Google Cloud Platform the BrightInsight Platform supports and optimizes regulated drugs devices and software through integrated data and actionable insights BrightInsight a Flex company today announced that it has receiv...

HitGen and Kaken Enter Into License Agreement: HitGen Inc. announced today that HitGen Inc. and Kaken Pharmaceutical Co. Ltd. have entered into a license agreement to develop a novel class of drugs. The licensed compounds were identified using HitGens leading technology platform...

ICYMI: STAT Plus Beset by a failed merger mounting losses and manufacturing headaches Akorn sought to compensate for its woes with steep price hikes on many of its drugs. httpsbuff.ly2uSDjDPÂ: STAT Plus Beset by a failed merger mounting losses and manufacturing headaches Akorn sought to compensate for its woes with steep price hikes on many of its drugs. httpsbuff.ly2uSDjDP

ICYMI: STAT Plus A troubled drug maker attempts to compensate for its problems by taking huge price hikes: Beset by a failed merger mounting losses and manufacturing headaches Akorn sought to compensate for its woes with steep price hikes on many of its drugs.

ICYMI: Canadian Friends of Sheba Medical Center Holds VIP Reception with Sheba Director General in Toronto: Canadian Friends of Sheba Medical Center Tel HaShomer recently held an exclusive reception in Toronto with the hospitals Director General Prof. Yitshak Kreiss. The gathering was an opportunity for local supporters to greet and meet Prof. Kreiss as he revea...

ICYMI: Sandoz launches generic Remodulin

ICYMI: Proud to receive an ENERGYSTAR Partner of the Year award in Sustained Excellence for the 12th consecutive year. Learn more about our energy management efforts httpmerck.us2TYgA89Â ENERGYSTARawardspic.twitter.comdUi3J3x1zW : Proud to receive an ENERGYSTAR Partner of the Year award in Sustained Excellence for the 12th consecutive year. Learn more about our energy management efforts httpmerck.us2TYgA89 ENERGYSTARawards pic.twitter.comdUi3J3x1zW

ICYMI: Intalere Teams with Ambry Genetics to Offer Healthcare Providers Advanced Genetic Testing for Cancer Risk Assessment: Intalere the healthcare industry leader in delivering optimal cost quality and clinical outcomes today announced a new partnership with Ambry Genetics a leading clinical genetic testing company. The collaboration will enable Intalere to offer its healthcar...

ICYMI: Regeneron in $1bn RNAi pact with Alnylam: Regeneron and Alnylam sign discovery agreement that could advance 30 targets within CNS and ocular disorders during an initial fiveyear discovery period.

RNAi partnership by Alnylam and Regeneron aims to develop treatments for CNS eye liver disorders httpow.lyksvU30oo6H3Â: RNAi partnership by Alnylam and Regeneron aims to develop treatments for CNS eye liver disorders httpow.lyksvU30oo6H3